AVID BIOSERVICES INC's ticker is CDMO and the CUSIP is 05368M106. A total of 190 filers reported holding AVID BIOSERVICES INC in Q4 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,276 | -62.2% | 3,419 | -44.0% | 0.00% | -66.7% |
Q2 2023 | $85,343 | +164021.2% | 6,109 | +117.5% | 0.00% | +50.0% |
Q1 2023 | $52 | -25.7% | 2,809 | -45.0% | 0.00% | -33.3% |
Q4 2022 | $70 | -99.9% | 5,105 | +35.1% | 0.00% | +200.0% |
Q3 2022 | $72,000 | -61.9% | 3,778 | -69.5% | 0.00% | -75.0% |
Q2 2022 | $189,000 | +455.9% | 12,405 | +642.4% | 0.00% | – |
Q1 2022 | $34,000 | -82.4% | 1,671 | -74.8% | 0.00% | -100.0% |
Q4 2021 | $193,000 | -24.3% | 6,624 | -44.0% | 0.00% | -57.1% |
Q3 2021 | $255,000 | +311.3% | 11,825 | +389.4% | 0.01% | +250.0% |
Q2 2021 | $62,000 | -31.1% | 2,416 | -50.8% | 0.00% | 0.0% |
Q1 2021 | $90,000 | -2.2% | 4,911 | -38.8% | 0.00% | -33.3% |
Q4 2020 | $92,000 | -80.1% | 8,025 | -86.8% | 0.00% | -40.0% |
Q3 2020 | $463,000 | +486.1% | 60,706 | +402.0% | 0.01% | +66.7% |
Q2 2020 | $79,000 | +172.4% | 12,094 | +127.6% | 0.00% | +50.0% |
Q3 2019 | $29,000 | -6.5% | 5,313 | -2.1% | 0.00% | 0.0% |
Q2 2019 | $31,000 | -64.8% | 5,425 | -73.8% | 0.00% | -60.0% |
Q1 2019 | $88,000 | +2100.0% | 20,691 | +2232.7% | 0.01% | – |
Q4 2018 | $4,000 | – | 887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AltraVue Capital, LLC | 3,009,189 | $28,406,744 | 3.38% |
Sargent Investment Group, LLC | 720,961 | $6,805,872 | 1.64% |
Ranger Investment Management | 2,281,112 | $21,533,697 | 1.43% |
AWM Investment Company, Inc. | 999,926 | $9,439,301 | 1.39% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,186,639 | $11,201,871 | 0.72% |
Roubaix Capital, LLC | 77,843 | $734,838 | 0.54% |
SNYDER CAPITAL MANAGEMENT L P | 2,230,931 | $21,059,989 | 0.48% |
GENEVA CAPITAL MANAGEMENT LLC | 2,258,671 | $21,321,857 | 0.45% |
B. Riley Asset Management, LLC | 110,702 | $1,045,027 | 0.42% |
PALISADE CAPITAL MANAGEMENT, LP | 1,572,840 | $14,847,610 | 0.41% |